Pages that link to "Q45785307"
Jump to navigation
Jump to search
The following pages link to Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression (Q45785307):
Displayed 50 items.
- Epstein-Barr virus and Burkitt lymphoma (Q24669890) (← links)
- NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease (Q24675566) (← links)
- X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells (Q24676168) (← links)
- Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients (Q26823898) (← links)
- Optimization of the MHC class I peptide cargo is dependent on tapasin (Q28215565) (← links)
- Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells (Q28295513) (← links)
- Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine (Q28749468) (← links)
- Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells (Q30587658) (← links)
- Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization (Q30701323) (← links)
- c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. (Q32084062) (← links)
- Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses. (Q33366578) (← links)
- The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation (Q33396983) (← links)
- IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter (Q33640213) (← links)
- Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy (Q33732738) (← links)
- Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression (Q33783532) (← links)
- Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma (Q33827463) (← links)
- Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. (Q33834888) (← links)
- Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1 (Q33908810) (← links)
- Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors (Q33947906) (← links)
- Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency (Q33957851) (← links)
- MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells (Q34048911) (← links)
- Molecular virology of Epstein-Barr virus (Q34225554) (← links)
- Immunotherapeutic strategies for EBV-associated malignancies. (Q34265151) (← links)
- A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy (Q34310840) (← links)
- Role for early-differentiated natural killer cells in infectious mononucleosis (Q34353708) (← links)
- T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance (Q34452013) (← links)
- Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. (Q34658852) (← links)
- PML nuclear bodies and SATB1 are associated with HLA class I expression in EBV+ Hodgkin lymphoma (Q34979670) (← links)
- Immunological aspects of Epstein-Barr virus infection (Q35017852) (← links)
- T cell-based therapies for EBV-associated malignancies (Q35609768) (← links)
- Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells (Q35661383) (← links)
- Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. (Q35691576) (← links)
- Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target (Q35775750) (← links)
- Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. (Q35787708) (← links)
- Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain (Q35891377) (← links)
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination (Q35994831) (← links)
- Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition (Q36161320) (← links)
- Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes (Q36327157) (← links)
- BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells (Q36371299) (← links)
- The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli (Q36414572) (← links)
- Mechanisms of immune evasion by tumors (Q36490750) (← links)
- Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205. (Q36654119) (← links)
- c-MYC impairs immunogenicity of human B cells (Q36786058) (← links)
- Potential selection of LMP1 variants in nasopharyngeal carcinoma (Q36944141) (← links)
- Modulation of B-cell exosome proteins by gamma herpesvirus infection (Q37068487) (← links)
- Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression (Q37204614) (← links)
- Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+ T cell immunity (Q37652046) (← links)
- Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes (Q37692921) (← links)
- Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells. (Q37713982) (← links)
- Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications (Q38035301) (← links)